Skip to content

The effect of maltodextrin on the recovery of lung function with a spirometer and muscle strength with a handgrip dynamometer in gynaecological post laparotomy patients under general anaesthesia

The effect of maltodextrin on the recovery of lung function with a spirometer and muscle strength with a handgrip dynamometer in gynaecological post laparotomy patients under general anaesthesia : A Double-blind Randomized Controlled Trial

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20241208003
Enrollment
58
Registered
2024-12-08
Start date
2024-11-25
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Forced expiratory volume in one second Forced vital capacity Handgrip strength Neutrophil-to-lymphocyte ratio Gynecological post-laparotomy patients under general anesthesia. Spirometry Forced Expiratory Volume (FEV1) Vital Capacity (FVC) Hand grip Strength Handgrip dynamometer Neutrophil-Lymphocyte Ratio (NLR) Maltodextrin

Interventions

Water with yellow-flavored syrup (400 ml) the night before surgery at 10:00 PM and water with the same syrup (200 ml) 2 hours before surgery,50 g of maltodextrin mixed with yellow-flavored syrup (400
Placebo,Maltodextrin

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with ASA physical status I or II Patients with nutritional status classified as SGA A Normal gastrointestinal motility with no signs of obstruction METS score greater than 4 Hemoglobin level exceeding 10 g/dl

Exclusion criteria

Exclusion criteria: Patients with intellectual disabilities. Patients experiencing motor or sensory aphasia. Patients with a history of cerebrovascular disease. Patients diagnosed with acute retinal detachment. Patients suffering from upper respiratory tract infections. Patients with a history of diabetes mellitus who maintain normal random or fasting blood glucose levels but have discontinued diabetes treatment without a doctor's recommendation, or those with an HbA1c greater than seven percent within the past six months. Patients whose body mass index is categorized as underweight or obese. Patients who are unwilling to participate, as indicated by their refusal to provide informed consent

Design outcomes

Primary

MeasureTime frame
FEV1, FVC, Handgrip Strength 24 hours preoperative, 24 hours postoperative, 48 hours postoperative Spirometry, Handgrip strength test

Secondary

MeasureTime frame
neutrophil-to-lymphocyte ratio 24 hours preoperative, 24 hours postoperative complete blood count

Countries

Indonesia

Contacts

Public ContactChandra Gunawan

Faculty of Medicine Udayana University

crgbius2021@gmail.com081331731164

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026